Gitlin, Michael
Bauer, Michael
Funding for this research was provided by:
Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
Article History
Received: 15 September 2023
Accepted: 8 November 2023
First Online: 16 November 2023
Declarations
:
: Not applicable.
: Not applicable.
: MG has no conflicts of interest to declare with respect to the research, authorship and/or publication of this article. MB has received research grants by the Deutsche Forschungsgemeinschaft (DFG), Bundesministerium für Bildung und Forschung (BMBF), Gemeinsamer Bundesausschuss- Innovationsausschuss, European Commission, Sächsisches Staatsministerium für Wissenschaft, Kultur und Tourismus (SMWK); SAB, and served as consultant, advisor or speaker for Biogen, COMPASS Pathfinder, GH Research, F. Hoffmann-La Roche, Janssen, Janssen-Cilag, Livanova Deutschland GmbH, Novartis, Sunovion, Takeda, neuraxpharm, Shire International GmbH, Aristo, Servier Deutschland GmbH and Hexal AG.